{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:24:25Z","timestamp":1788899065177,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier","isbn-type":[{"value":"9780323955638","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.pmbts.2023.03.027","type":"book-chapter","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:43:36Z","timestamp":1683089016000},"page":"275-302","source":"Crossref","is-referenced-by-count":5,"title":["Phages for treatment of Staphylococcus aureus infection"],"prefix":"10.1016","author":[{"given":"Safia","family":"Samir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2023.03.027_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104722","article-title":"Assessment of eugenol inhibitory effect on biofilm formation and biofilm gene expression in methicillin resistant Staphylococcus aureus clinical isolates in Egypt","author":"El-Far","year":"2021","journal-title":"Infection, Genet Evolution"},{"issue":"June","key":"10.1016\/bs.pmbts.2023.03.027_bib2","first-page":"1","article-title":"Bacteriophage therapy for Staphylococcus aureus infections: A review of animal models, treatments, and clinical trials","volume":"12","author":"Plumet","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.01263-20","article-title":"Genes influencing phage host range in Staphylococcus aureus on a species-wide scale","volume":"6","author":"Moller","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib4","unstructured":"Larsen J, Raisen CL, Ba X, et al. Emergence of methicillin resistance predates the clinical use of antibiotics|Enhanced Reader. 2022;602(May 2021)."},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-021-00893-z","article-title":"Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?","volume":"10","author":"Pelfrene","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"issue":"November","key":"10.1016\/bs.pmbts.2023.03.027_bib6","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.2147\/IDR.S335582","article-title":"High rates of aminoglycoside methyltransferases associated with metallo-beta-lactamases in multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a tertiary care hospital in Egypt","volume":"14","author":"El-Far","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib7","first-page":"1","article-title":"Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens","volume":"June","author":"Khambhati","year":"2022","journal-title":"Bioeng Transl Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.03.027_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/app12041958","article-title":"Exposure and health effects of bacteria in healthcare units: An overview","volume":"12","author":"Monteiro","year":"2022","journal-title":"Appl Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.03.027_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0124280","article-title":"Strain specific phage treatment for Staphylococcus aureus infection is influenced by host immunity and site of infection","volume":"10","author":"Pincus","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.03.027_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v10040178","article-title":"Expert opinion on three phage therapy related topics: Bacterial phage resistance, phage training and prophages in bacterial production strains","volume":"10","author":"Rohde","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1872208315666210121094311","article-title":"Bacteriophages as therapeutic agents: alternatives to antibiotics","volume":"15","author":"Samir","year":"2021","journal-title":"Recent Pat Biotechnol"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.03.027_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AEM.00209-19","article-title":"Determinants of phage host range in Staphylococcus species","volume":"85","author":"Moller","year":"2019","journal-title":"Appl Environ Microbiology"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.03.027_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/17425247.2017.1252329","article-title":"Inhaled phage therapy: A promising and challenging approach to treat bacterial respiratory infections","volume":"14","author":"Bodier-Montagutelli","year":"2017","journal-title":"Expert Opin Drug Delivery"},{"issue":"01","key":"10.1016\/bs.pmbts.2023.03.027_bib14","article-title":"Phage therapy: A potential novel therapeutic treatment of MRSA","volume":"03","author":"Gildea","year":"2022","journal-title":"SunText Rev Virol"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.03.027_bib15","first-page":"64","article-title":"Initiation of P22 infection at the phage centennial","volume":"2","author":"Ayariga","year":"2018","journal-title":"Front Sci Technol Eng Math"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.03.027_bib16","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.3390\/v4123316","article-title":"The staphylococci phages family: An overview","volume":"4","author":"Deghorain","year":"2012","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.03.027_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11050555","article-title":"Bacteriophage tail proteins as a tool for bacterial pathogen recognition\u2014A literature review","volume":"11","author":"Filik","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib18","unstructured":"Reveals W, genome A, Bacteriophages T. Whole-genome analysis reveals that bacteriophages promote environmental adaptation of Staphylococcus aureus via gene. Published online 2022."},{"issue":"9","key":"10.1016\/bs.pmbts.2023.03.027_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091885","article-title":"Phage therapy against Staphylococcus aureus: Selection and optimization of production protocols of novel broad-spectrum silviavirus phages","volume":"14","author":"Kolenda","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib20","unstructured":"O\u2019flaherty S, Flynn J, Coffey A, Fitzgerald G, Meaney B, Ross P. Molecular characterisation of bacteriophage k towards applications for the biocontrol of pathogenic Staphylococci. 2016;(June)."},{"issue":"2","key":"10.1016\/bs.pmbts.2023.03.027_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics7020037","article-title":"Comparison of Staphylococcus phage K with close phage relatives commonly employed in phage therapeutics","volume":"7","author":"Ajuebor","year":"2018","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2180-11-226","article-title":"A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein","volume":"11","author":"Paul","year":"2011","journal-title":"BMC Microbiology"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-27037-6","article-title":"Multi-species host range of staphylococcal phages isolated from wastewater","volume":"12","author":"G\u00f6ller","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.03.027_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/21597081.2016.1219440","article-title":"Characterization of novel Staphylococcus aureus lytic phage and defining their combinatorial virulence using the OmniLog\u00ae system","volume":"6","author":"Estrella","year":"2016","journal-title":"Bacteriophage"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-75637-x","article-title":"Contribution of podoviridae and myoviridae bacteriophages to the effectiveness of anti-staphylococcal therapeutic cocktails","volume":"10","author":"Kornienko","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.03.027_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms9020261","article-title":"Bacteriophages as a potential 360-degree pathogen control strategy","volume":"9","author":"D\u2019accolti","year":"2021","journal-title":"Microorganisms"},{"issue":"April","key":"10.1016\/bs.pmbts.2023.03.027_bib27","first-page":"1","article-title":"JD419, a Staphylococcus aureus phage with a unique morphology and broad host range","volume":"12","author":"Feng","year":"2021","journal-title":"Front Microbiol"},{"issue":"23","key":"10.1016\/bs.pmbts.2023.03.027_bib28","doi-asserted-by":"crossref","first-page":"13099","DOI":"10.1128\/JVI.02350-12","article-title":"Bacteriophage P70: Unique morphology and unrelatedness to other listeria bacteriophages","volume":"86","author":"Schmuki","year":"2012","journal-title":"J Virology"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.03.027_bib29","article-title":"Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.03.027_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/AEM.01848-10","article-title":"Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2","volume":"77","author":"Hsieh","year":"2011","journal-title":"Appl Environ Microbiology"},{"issue":"May","key":"10.1016\/bs.pmbts.2023.03.027_bib31","article-title":"Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome","volume":"151","author":"Nath","year":"2022","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.03.027_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ph14101019","article-title":"Phage cocktail development for bacteriophage therapy: Toward improving spectrum of activity breadth and depth","volume":"14","author":"Abedon","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.03.027_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116116","article-title":"APTC-C-SA01: A novel bacteriophage cocktail targeting Staphylococcus aureus and MRSA biofilms","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/v11010088","article-title":"Design and preclinical development of a phage product for the treatment of antibiotic-resistant Staphylococcus aureus infections","volume":"11","author":"Lehman","year":"2019","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.03.027_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/v12050559","article-title":"Efficacy of lytic phage cocktails on Staphylococcus aureus and Pseudomonas aeruginosa in mixed-species planktonic cultures and biofilms","volume":"12","author":"Kifelew","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-020-01891-8","article-title":"Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus","volume":"20","author":"Kifelew","year":"2020","journal-title":"BMC Microbiology"},{"issue":"April","key":"10.1016\/bs.pmbts.2023.03.027_bib37","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2147\/IDR.S362743","article-title":"Exploring the benefits of metal ions in phage cocktail for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection","volume":"15","author":"Li","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.03.027_bib38","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.sjbs.2022.03.019","article-title":"Isolation and characterization of lytic bacteriophages from sewage at an egyptian tertiary care hospital against methicillin-resistant Staphylococcus aureus clinical isolates","volume":"29","author":"Samir","year":"2022","journal-title":"Saudi J Biol Sci"},{"issue":"January","key":"10.1016\/bs.pmbts.2023.03.027_bib39","first-page":"1","article-title":"Animal models of phage therapy","volume":"12","author":"Penziner","year":"2021","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.03.027_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms9020206","article-title":"Animal models in the evaluation of the effectiveness of phage therapy for infections caused by gram-negative bacteria from the ESKAPE group and the reliability of its use in humans","volume":"9","author":"Cie\u015blik","year":"2021","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.03.027_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v14030620","article-title":"Efficacy assessment of phage therapy in treating Staphylococcus aureus-induced mastitis in mice","volume":"14","author":"Teng","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib42","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"176","author":"Diering","year":"2018","journal-title":"Physiol & Behav"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib43","article-title":"Mouse models for infectious diseases caused by Staphylococcus aureus","author":"Kim","year":"2014","journal-title":"J Immunological Methods"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.03.027_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/spectrum.02716-21","article-title":"Toward optimization of a rabbit model of Staphylococcus aureus (USA300) skin and soft tissue infection","volume":"10","author":"Malachowa","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.03.027_bib45","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.49.3.1220-1221.2005","article-title":"Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model","volume":"49","author":"Wills","year":"2005","journal-title":"Antimicrobial Agents Chemotherapy"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.03.027_bib46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.14737\/journal.aavs\/2016\/4.11.593.603","article-title":"Activity of isolated staphylococcal bacteriophage in treatment of experimentally induced chronic osteomyelitis in rabbits","volume":"4","author":"Ibrahim","year":"2016","journal-title":"Adv Anim Vet Sci"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.03.027_bib47","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijmm.2017.09.014","article-title":"Wild rodents and shrews are natural hosts of Staphylococcus aureus","volume":"308","author":"Mrochen","year":"2018","journal-title":"Int J Med Microbiology"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.03.027_bib48","first-page":"1","article-title":"Staphylococcus aureus gene expression in a rat model of infective endocarditis","volume":"6","author":"Hanses","year":"2014","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1574-6968.2006.00567.x","article-title":"Persistence of Staphylococcus aureus L-form during experimental lung infection in rats","volume":"268","author":"Michailova","year":"2007","journal-title":"FEMS Microbiology Lett"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/1751-0147-51-14","article-title":"A pig model of acute Staphylococcus aureus induced pyemia","volume":"51","author":"Nielsen","year":"2009","journal-title":"Acta Veterinaria Scandinavica"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.03.027_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.femsim.2004.11.003","article-title":"Invertebrates as animal models for Staphylococcus aureus pathogenesis: A window into host-pathogen interaction","volume":"43","author":"Garc\u00eda-Lara","year":"2005","journal-title":"FEMS Immunology Med Microbiology"},{"issue":"166","key":"10.1016\/bs.pmbts.2023.03.027_bib52","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0121-2022","article-title":"Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations","volume":"31","author":"Mitropoulou","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.03.027_bib53","doi-asserted-by":"crossref","DOI":"10.12968\/jowc.2009.18.6.42801","article-title":"Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial","volume":"18","author":"Rhoads","year":"2013","journal-title":"J Wound Care"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.03.027_bib54","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamaoto.2019.1191","article-title":"Safety and tolerability of bacteriophage therapy for chronic rhinosinusitis due to Staphylococcus aureus","volume":"145","author":"Ooi","year":"2019","journal-title":"JAMA Otolaryngol - Head Neck Surg"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.03.027_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics7040087","article-title":"Resolving digital staphylococcal osteomyelitis using bacteriophage\u2014A case report","volume":"7","author":"Fish","year":"2018","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib56","first-page":"1","article-title":"Clinical indications and compassionate use of phage therapy: Personal experience and literature review with a focus on osteoarticular infections","volume":"11","author":"Patey","year":"2019","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.03.027_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v13061182","article-title":"Successful treatment of Staphylococcus aureus prosthetic joint infection with bacteriophage therapy","volume":"13","author":"Ramirez-Sanchez","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib58","doi-asserted-by":"crossref","DOI":"10.1080\/21597081.2015.1020260","article-title":"Phage therapy of pulmonary infections","volume":"5","author":"Abedon","year":"2015","journal-title":"Bacteriophage"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib59","doi-asserted-by":"crossref","unstructured":"Yoon R, Chang K, Wallin M, et al. HHS Public Access. Published online 2019:76-86. \u3008https:\/\/doi.org\/10.1016\/j.addr.2018.08.001.Phage\u3009.","DOI":"10.1016\/j.addr.2018.08.001"},{"issue":"October 2019","key":"10.1016\/bs.pmbts.2023.03.027_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2020.04.003","article-title":"High frequency acoustic nebulization for pulmonary delivery of antibiotic alternatives against Staphylococcus aureus","volume":"151","author":"Marqus","year":"2020","journal-title":"Eur J Pharmaceutics Biopharmaceutics: Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.03.027_bib61","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1751-7915.2011.00259.x","article-title":"Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens","volume":"4","author":"Kvachadze","year":"2011","journal-title":"Microb Biotechnol"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.03.027_bib62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1067\/j.cpsurg.2014.06.001","article-title":"Necrotizing soft tissue infections: Review and current concepts in treatment, systems of care, and outcomes","volume":"51","author":"Hakkarainen","year":"2014","journal-title":"Curr Probl Surg"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib63","doi-asserted-by":"crossref","unstructured":"Zhvania P, Hoyle NS, Nadareishvili L, Nizharadze D, Hoyle NS. Phage therapy in a 16-year-old boy with netherton syndrome. 2017;4(July):1-5. \u3008https:\/\/doi.org\/10.3389\/fmed.2017.00094\u3009.","DOI":"10.3389\/fmed.2017.00094"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.03.027_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/23744235.2017.1392039","article-title":"Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review","volume":"50","author":"Asgeirsson","year":"2018","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib65","doi-asserted-by":"crossref","first-page":"e01987-19","DOI":"10.1128\/AAC.01987-19","article-title":"What\u2019s old is new again: bacteriophage therapy in the 21st century","volume":"64","author":"Aslam","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.03.027_bib66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5694\/mja2.50274","article-title":"Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus","volume":"211","author":"Gilbey","year":"2019","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.03.027_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9050232","article-title":"Bacteriophage therapy for critical infections related to cardiothoracic surgery","volume":"9","author":"Rubalskii","year":"2020","journal-title":"Antibiotics"},{"issue":"October","key":"10.1016\/bs.pmbts.2023.03.027_bib68","article-title":"Robust approaches for the production of active ingredient and drug product for human phage therapy","volume":"10","author":"Mutti","year":"2019","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.03.027_bib69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): A randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"March","key":"10.1016\/bs.pmbts.2023.03.027_bib70","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy","volume":"249","author":"Malik","year":"2017","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib71","article-title":"Basic guidelines for bacteriophages isolation and characterization","author":"Samir","year":"2022","journal-title":"Recent Pat Biotechnol"},{"key":"10.1016\/bs.pmbts.2023.03.027_bib72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1872208314666201112105053","article-title":"A novel cell-based in vitro assay for antiviral activity of interferons \u03b1, \u03b2, and \u03b3 by qPCR of mxa gene expression","volume":"15","author":"Saber","year":"2021","journal-title":"Recent Pat Biotechnol"}],"container-title":["Progress in Molecular Biology and Translational Science","Phage Therapy - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187711732300087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187711732300087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T15:12:38Z","timestamp":1698678758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187711732300087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323955638"],"references-count":72,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2023.03.027","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}